CLASS I ONGOING Drug recall · Reported 11 Mar 2026 · FDA Enforcement Report
MR. 7 Super blister card recalled by StuffbyNainax
StuffbyNainax is recalling MR. 7 Super blister card. The recall was initiated on 15 Dec 2025 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0397-2026
- FDA event ID
- 98256
- Recalling firm
- StuffbyNainax, Huntsville, TX
- Classification
- Class I
- Status
- Ongoing
- Recall initiated
- 15 Dec 2025
- FDA classified
- 18 Mar 2026
- Reported
- 11 Mar 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Labeling Errors
Timeline
| 15 Dec 2025 | Recall initiated by company | |
| 11 Mar 2026 | Published in enforcement report | +86 days |
| 18 Mar 2026 | Classified by FDA | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
Product as listed by the FDA
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Where it was distributed
Product was distributed to 4 customers in the US.
Questions about this recall
Why was it recalled?
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
Which lots are affected?
All codes; Exp 12/31/2029
Where was it sold?
Product was distributed to 4 customers in the US.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.